EPREmergency Preparedness & Response
- Specific Hazards
- Bioterrorism
- A–Z
- Anthrax
- Arenaviruses
- Botulism
- Brucella
- Cholera
- Ebola virus
- E. coli
- Food safety threats
- Glanders
- Lassa fever
- Marburg virus
- Melioidosis
- Plague
- Q fever
- Salmonella
- Shigella
- Smallpox
- Smallpox Basics
- Vaccine Basics
- Clinicians
- Vaccination Q & A (for professionals)
- Health Officials
- People Selected for Response Teams
- Diagnosis/
Evaluation - Lab Testing
- Infection Control
- Surveillance & Investigation
- Preparation & Planning
- Response
- Vaccination
- Images
- Medical Management
- Training & Education
- References
- Tularemia
- Typhoid fever
- Viral hemorrhagic fevers
- List by Category
- Fact Sheets
- Case Definitions
- Training
- Surveillance
- Preparation & Planning
- First Responders
- Lab Info
- A–Z
- Chemical
- A–Z
- Abrin
- Adamsite
- Ammonia
- Arsenic
- Arsine
- Barium
- Benzene
- Brevetoxin
- Bromine
- BZ
- Carbon monoxide
- Chlorine
- Chromium
- Colchicine
- Cyanide
- Digitalis
- Ethylene glycol
- Hydrazine
- Hydrofluoric acid
- Lewisite
- Melamine
- Mercury
- Methyl bromide
- Methyl isocyanate
- Nicotine
- Nitrogen mustard
- Opioids
- Organic solvents
- Osmium tetroxide
- Paraquat
- Phosgene
- Phosgene oxime
- Phosphine
- Phosphorus
- Pulmonary agents
- Ricin
- Sarin
- Saxitoxin
- Selenium
- Sodium azide
- Sodium monofluoroacetate
- Soman
- Strychnine
- Sulfur mustard
- Sulfuryl Fluoride
- Super Warfarin
- Tabun
- Tetrodotoxin
- Thallium
- Trichothecene
- Unidentified Chemical
- VX
- List by Category
- Chemical-Specific Fact Sheets
- Toxicology FAQs
- Case Definitions
- Toxic Syndrome Descriptions
- Toxicological Profiles
- Training
- First Responders
- Medical Management
- Emergency Response Cards
- Lab Info
- Surveillance
- Preparation & Planning
- A–Z
- Radiation
- Mass Casualties
- Natural Disasters & Severe Weather
- Recent Outbreaks & Incidents
- Bioterrorism
- Preparedness for All Hazards
- What CDC Is Doing
- What You Can Do
- What's New
Smallpox Vaccination: Adverse Events
Information for the public can be found on the Smallpox Vaccine page.
On this page:
General Resources for Professionals
- Q & A: Adverse Events and Vaccine Safety
Frequently asked questions and answers for professionals
Mar 1, 2005
(last reviewed Jun 6, 2005) - Clinical Evaluation Tools for Smallpox Vaccine Adverse Reactions
Tools for clinicians
Mar 25, 2003
(last reviewed Feb 21, 2006) - Fact Sheet: Medical Management of Smallpox Vaccine Adverse Reactions
For clinicians. Includes information on the two medications (Vaccinia Immune Globulin & Cidofovir) that may help persons who have certain serious reactions to the vaccine
Feb 11, 2003
(last reviewed Feb 21, 2006) - Fact Sheet:
Investigational Vistide® (Cidofovir) Information
Drugs used to treat reactions to the smallpox vaccine
Jan 16, 2003
(last reviewed Feb 21, 2006) - Fact Sheet:
Investigational Vaccinia Immune Globulin (VIG) Information
Drugs used to treat reactions to the smallpox vaccine
Jan 16, 2003
(last reviewed Feb 21, 2006) - Fact Sheet: Smallpox (Vaccinia) Vaccine Adverse Event Reporting
For clinicians
Feb 19, 2003
(last reviewed Feb 21, 2006) - Reactions to Smallpox Vaccinations
Graphic clinical images of reactions to smallpox vaccinations.
Oct 1, 2002
(last reviewed Feb 21, 2006) - Fact Sheet: Adverse Reactions Following Smallpox Vaccination
For clinicians
Mar 28, 2003
(last reviewed Feb 21, 2006) -
Fact Sheet: Smallpox Vaccine & Heart Problems: Information
for People Who Have Recently Received the Smallpox Vaccine
For recent vaccinees
Mar 31, 2003
(last reviewed Feb 21, 2006) -
Guidance for the Healthcare Community Concerning Section 304 of the Homeland Security Act
From Smallpox Q&A
Jan 17, 2003
(last reviewed Feb 21, 2006) - Algorithm for Evaluating Suspected Vaccinia Vaccination (Smallpox Vaccination) Pericarditis-Myocarditis (103 KB/7 pages)
DoD Vaccine Healthcare Center (VHC), Version 21 July 05
The preparation of the Smallpox Myopericarditis Algorithm was due to the efforts of the many individuals affiliated with the VHC Network.
Registries
-
Smallpox Vaccine Compensation Program
US Dept of Health & Human Services -
Interim Protocol for Blood and/or Vaccinia Virus Exposures (393 KB/14 pages)
Protocol for Investigating and Reporting Blood and/or Vaccinia Virus Exposures During Smallpox Vaccination
Feb 24, 2003
(last reviewed Feb 21, 2006) - Notice to Readers: National Smallpox Vaccine in Pregnancy Registry
MMWR 2003 Mar 28;52(12):256.
PDF (1.21 MB/28 pages)
References
-
Smallpox Vaccination & Adverse Reactions: Guidance for Clinicians
MMWR 2003 Feb 21;52(RR04):1-28.
PDF (5.36 MB/32 pages) - Smallpox Vaccination & Adverse Reactions: A Teaching Slide Set
Slide set that reviews key points in the MMWR report Smallpox Vaccination & Adverse Events: Guidance for clinicians
Aug 7, 2003
(last reviewed Feb 21, 2006) -
Notice to Readers: Supplemental Recommendations on Adverse Events Following Smallpox Vaccine in the Pre-Event Vaccination Program: Recommendations of the ACIP
PDF (1.08 MB/28 pages) -
Update: Cardiac-Related Events During the Civilian Smallpox Vaccination Program United States, 2003
MMWR 2003 May 30;52(21);492-496.
PDF (267 KB/24 pages) - Chart: Smallpox Vaccine Adverse Event Rates, 1968
Dec 31, 2002
(last reviewed Feb 21, 2006)
- Share
- Add this to...
- Favorites
- Del.icio.us
- Digg
- Google Bookmarks
- Technorati
- Yahoo MyWeb
- Updates
- Subscribe
- Listen
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
24 Hours/Every Day - cdcinfo@cdc.gov